120 related articles for article (PubMed ID: 18545237)
1. Reduced-intensity conditioning in children: a reappraisal in 2008.
Yaniv I; Stein J;
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S18-22. PubMed ID: 18545237
[TBL] [Abstract][Full Text] [Related]
2. Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases.
Satwani P; Cooper N; Rao K; Veys P; Amrolia P
Bone Marrow Transplant; 2008 Jan; 41(2):173-82. PubMed ID: 18037944
[TBL] [Abstract][Full Text] [Related]
3. Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: end of the beginning and future challenges.
Satwani P; Harrison L; Morris E; Del Toro G; Cairo MS
Biol Blood Marrow Transplant; 2005 Jun; 11(6):403-22. PubMed ID: 15931629
[TBL] [Abstract][Full Text] [Related]
4. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
Turner BE; Kambouris ME; Sinfield L; Lange J; Burns AM; Lourie R; Atkinson K; Hart DN; Munster DJ; Rice AM
Transplantation; 2008 Oct; 86(7):968-76. PubMed ID: 18852664
[TBL] [Abstract][Full Text] [Related]
5. The hope and the reality of reduced intensity transplants in children with malignant diseases.
Stein J; Dini G; Yaniv I;
Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S39-43. PubMed ID: 15812529
[TBL] [Abstract][Full Text] [Related]
6. Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience.
Gómez-Almaguer D; Ruiz-Argüelles GJ; Tarín-Arzaga Ldel C; González-Llano O; Jaime-Pérez JC; López-Martínez B; Cantú-Rodríguez OG; Herrera-Garza JL
Biol Blood Marrow Transplant; 2003 Mar; 9(3):157-61. PubMed ID: 12652465
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico.
Llano OG; Perez JC; Rodriguez OC; Guerra CM; Aguirre HG; Garza JL; Rodriguez-Romo L; Almaguer DG
Pediatr Hematol Oncol; 2008; 25(1):39-47. PubMed ID: 18231953
[TBL] [Abstract][Full Text] [Related]
8. Non-endocrine late complications in children after allogeneic haematopoietic SCT.
Faraci M; Békássy AN; De Fazio V; Tichelli A; Dini G;
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S49-57. PubMed ID: 18545245
[TBL] [Abstract][Full Text] [Related]
9. Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases.
Satwani P; Morris E; Bradley MB; Bhatia M; van de Ven C; Cairo MS
Pediatr Blood Cancer; 2008 Jan; 50(1):1-8. PubMed ID: 17668859
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Barosi G; Bacigalupo A
Curr Opin Hematol; 2006 Mar; 13(2):74-8. PubMed ID: 16456372
[TBL] [Abstract][Full Text] [Related]
11. Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States.
Aversa F
Bone Marrow Transplant; 2008 Mar; 41(5):473-81. PubMed ID: 18176612
[TBL] [Abstract][Full Text] [Related]
12. A retrospective review of the outcome after second or subsequent allogeneic transplantation.
Kedmi M; Resnick IB; Dray L; Aker M; Samuel S; Gesundheit B; Slavin S; Or R; Shapira MY
Biol Blood Marrow Transplant; 2009 Apr; 15(4):483-9. PubMed ID: 19285636
[TBL] [Abstract][Full Text] [Related]
13. Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction.
Kikuta A; Ito M; Mochizuki K; Akaihata M; Nemoto K; Sano H; Ohto H
Bone Marrow Transplant; 2006 Nov; 38(10):665-9. PubMed ID: 17013427
[TBL] [Abstract][Full Text] [Related]
14. 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
Sobecks RM; Dean R; Rybicki LA; Chan J; Theil KS; Macklis R; Andresen S; Kalaycio M; Pohlman B; Ferraro C; Cherni K; Sweetenham J; Copelan E; Bolwell BJ
Bone Marrow Transplant; 2008 Dec; 42(11):715-22. PubMed ID: 18711346
[TBL] [Abstract][Full Text] [Related]
15. Safety of hematopoietic stem cell transplantation in children less than three years of age.
Dvorak CC; Wright NB; Wong WB; Kristovich KM; Matthews EW; Weinberg KI; Amylon MD; Agarwal R
Pediatr Hematol Oncol; 2008 Dec; 25(8):705-22. PubMed ID: 19065437
[TBL] [Abstract][Full Text] [Related]
16. Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
Alousi A; de Lima M
Clin Adv Hematol Oncol; 2007 Jul; 5(7):560-70. PubMed ID: 17679930
[TBL] [Abstract][Full Text] [Related]
17. Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia.
George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
Pediatr Transplant; 2008 Feb; 12(1):14-9. PubMed ID: 18086256
[TBL] [Abstract][Full Text] [Related]
18. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
19. Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD.
Novitzky N; Thomas V; du Toit C; McDonald A
Bone Marrow Transplant; 2009 May; 43(10):779-85. PubMed ID: 19079315
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
